Last CNY12.66 CNY
Change Today +0.25 / 2.01%
Volume 21.9M
601607 On Other Exchanges
Symbol
Exchange
Shanghai
Berlin
OTC US
OTC US
Hong Kong
As of 3:05 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

shanghai pharmaceuticals-a (601607) Snapshot

Open
CNY12.44
Previous Close
CNY12.41
Day High
CNY12.72
Day Low
CNY12.36
52 Week High
10/14/13 - CNY17.10
52 Week Low
08/23/13 - CNY10.85
Market Cap
33.6B
Average Volume 10 Days
13.1M
EPS TTM
CNY0.82
Shares Outstanding
1.9B
EX-Date
05/26/14
P/E TM
15.5x
Dividend
CNY0.26
Dividend Yield
2.05%
Current Stock Chart for SHANGHAI PHARMACEUTICALS-A (601607)

Related News

No related news articles were found.

shanghai pharmaceuticals-a (601607) Related Businessweek News

No Related Businessweek News Found

shanghai pharmaceuticals-a (601607) Details

Shanghai Pharmaceuticals Holding Co., Ltd. is engaged in the research and development, manufacture, distribution, and retail of pharmaceutical products in China and internationally. The company offers products ranging from chemical and bio-pharms, modern Chinese medicine, healthcare products, medical devices, etc. in various therapeutic areas, including cardiovascular, systemic anti-infections, digestive system and immune-metabolism, neuropsychiatric, and antineoplastic. The company offers its products in various dosage forms, such as tablets, capsules, powder, mini-volume injections, eye-drops, inhalants, coagulants, etc. It also distributes vaccines and high-end consumables; and provides hospital service solutions focusing on the extended supply chain services, clinical supportive services, logistics, and information technology services. In addition, the company operates a chain of drugstores, pharmacies, joint-venture drugstores, DTP drugstores, etc. It has a strategic alliance with Shanghai Institute of Materia Medica. Shanghai Pharmaceuticals Holding Co., Ltd. was formerly known as Shanghai No. 4 Pharmaceutical Co., Ltd. The company was incorporated in 1994 and is based in Shanghai, China.

39,646 Employees
Last Reported Date: 03/28/14
Founded in 1994

shanghai pharmaceuticals-a (601607) Top Compensated Officers

Chairman, Convener of Strategy Committee and ...
Total Annual Compensation: --
Executive Director
Total Annual Compensation: --
Employee Supervisor
Total Annual Compensation: --
Chairman of the Supervisory Board
Total Annual Compensation: --
Supervisor
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

shanghai pharmaceuticals-a (601607) Key Developments

Shanghai Pharmaceuticals Holding Co., Ltd. Obtains Pharmaceutical Clinical Approval

Shanghai Pharmaceuticals Holding Co., Ltd. announced that "Recombinant fusion protein of human tumor necrosis factor receptor mutant and Fc fragment injection", a medicine co-developed with Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., has been granted a pharmaceutical clinical approval (No.2014L00653) by China Food and Drug Administration to permit it to enter the clinical trial stage. The medicine is mainly used for treatment of rheumatoid arthritis and other diseases. In addition, the application for pharmaceutical clinical trial on "Recombinant humanized anti-CD20 monoclonal antibody injection", a medicine introduced by the Company, has been accepted by China Food and Drug Administration, and passed the registration test and quality standards review by the National Institutes for Food and Drug Control of China. The Recombinant humanized anti-CD20 monoclonal antibody injection is mainly used for treatment of non-Hodgkin's lymphoma and other diseases.

Shanghai Pharmaceuticals Holding Co., Ltd. Adopts Cash Dividend for 2013 Payable on or Around June 30, 2014

The annual general meeting of Shanghai Pharmaceuticals Holding Co., Ltd. was held on May 8, 2014. At the meeting, the shareholders adopted an ordinary resolution to distribute a cash dividend of RMB 2.60 (before tax) for every ten shares for year 2013. The cash dividends are expected to be paid on or around 30 June 2014 to shareholders whose names appear on the H share register of members of the company on 23 May 2014.

Shanghai Pharmaceuticals Holding Co., Ltd. Reports Unaudited Consolidated and Parent Earnings Results for the First Quarter Ended March 31, 2014; Reports Asset Impairment Losses for the First Quarter Ended March 31, 2014

Shanghai Pharmaceuticals Holding Co., Ltd. reported unaudited consolidated and parent earnings results for the first quarter ended March 31, 2014. For the quarter, on consolidated basis, the company's total revenue was RMB 21,274,115,894.43 compared to RMB 19,590,198,049.21 a year ago. Operating profit was RMB 850,934,969.54 compared to RMB 885,915,212.91 a year ago. Total profit was RMB 855,432,822.86 compared to RMB 894,585,043.38 a year ago. Net profit was RMB 678,536,030.20 compared to RMB 736,830,239.81 a year ago. Net profit attributable to equity holders of the parent company was RMB 586,226,951.91 compared to RMB 625,664,019.79 a year ago. Diluted earnings per share was RMB 0.2180 compared to RMB 0.2327 a year ago. Net cash flows used in operating activities was RMB 564,590,746.82 compared to RMB 257,826,245.93 a year ago. Cash paid to acquire fixed assets, intangible assets and other long-term assets was RMB 178,967,422.44 compared to RMB 254,629,746.75 a year ago. Weighted average return on net assets was 2.24%. For the quarter, on parent basis, the company's revenue was RMB 819,918.91 compared to RMB 178,065.10 a year ago. Operating profit was RMB 101,110,742.59 compared to RMB 21,053,309.20 a year ago. Total profit was RMB 100,837,446.59 compared to RMB 21,091,337.84 a year ago. Net profit was RMB 100,837,446.59 compared to RMB 21,091,337.84 a year ago. Net cash flows used in operating activities was RMB 89,441,916.37 compared to cash flows from operating activities of RMB 35,607,489.92 a year ago. Cash paid to acquire fixed assets, intangible assets and other long-term assets was RMB 8,282,152.00 compared to RMB 6,716,212.41 a year ago. The company announced asset impairment losses of RMB 11,366,524.26 for the first quarter ended March 31, 2014 compared to RMB 10,836,293.91 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
601607:CH CNY12.66 CNY +0.25

601607 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY52.16 CNY +0.16
Jointown Pharmaceutical Group Co Ltd CNY14.21 CNY +0.29
Nanjing Pharmaceutical Co Ltd CNY5.86 CNY -0.05
Wanjia Group Holdings Ltd $0.62 HKD -0.01
View Industry Companies
 

Industry Analysis

601607

Industry Average

Valuation 601607 Industry Range
Price/Earnings 15.0x
Price/Sales 0.4x
Price/Book 1.2x
Price/Cash Flow 10.7x
TEV/Sales 0.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANGHAI PHARMACEUTICALS-A, please visit www.pharm-sh.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.